Mutual recognition agreements (MRAs) are agreements between two trading partners aimed at reducing technical barriers to trade. They are one of the themes covered in the trade negotiations between the UK and the EU. During a transitional period, the authorities assess each other`s pharmaceutical legislation, guidelines and regulatory systems under the agreement. The UK document reaffirms the importance of regulatory autonomy – “respect for the regulatory law of each party” – but also follows earlier considerations by proposing that the agreement “creates a framework for both parties to require the other to consider its technical regulation as equivalent to its own regulation.” In the Brexit negotiations, the UK government called for mutual recognition of the rules, including in Theresa May`s florence speech and as an option for future regulation of financial services, but refused by the EU. Although there has been little progress in accession negotiations, Turkey has gradually expanded its legislation on EU legislation to remove technical barriers. The results of THE CAB tests notified by Turkey are mutually recognised in the EU (and vice versa). The MRA with Israel is an agreement on the evaluation of compliance and acceptance of industrial products (ACAA). It is a specific type of MRI based on the alignment of the legal system and infrastructure of the country concerned with that of the EU. A traditional MRA is a mutual recognition agreement for “compliance assessment.” The transition period for drugs for human use, which falls under the agreement, ended on July 11, 2019: the Johnson government has moved away from these approaches. In its proposal for a comprehensive free trade agreement with the EU, the UK proposes an agreement on mutual recognition of compliance assessment that is “consistent” with the provisions of the EU agreement with Canada. A separate agreement on the certification of marine equipment is also proposed as part of the agreement between the EU and the United States. Trade agreements are trade agreements designed to facilitate market access and promote greater international harmonization of compliance standards while protecting consumer safety. The text of the Protocol on Mutual Recognition of the Results of the Compliance Assessment is part of the Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union and its Member States, on the other hand – Restrictions: Capacity findings apply to routine inspections.
In the future, the following types of products and inspections may be included in the scope of the agreement, pending further reflection: the European Union (EU) has signed mutual recognition agreements with third-country authorities.